nalidixic acid has been researched along with Anemia, Hypochromic in 2 studies
Anemia, Hypochromic: Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greer, M | 1 |
| Benini, A | 1 |
1 review available for nalidixic acid and Anemia, Hypochromic
| Article | Year |
|---|---|
Management of benign intracranial hypertension (pseudotumor cerebri).
Topics: Anemia, Hypochromic; Back Pain; Brain Diseases; Cerebral Ventriculography; Cerebrovascular Disorders | 1968 |
1 other study available for nalidixic acid and Anemia, Hypochromic
| Article | Year |
|---|---|
[Pseudotumor cerebri. Benign intracranial hypertension].
Topics: Adult; Anemia, Hypochromic; Female; Hormones; Humans; Male; Nalidixic Acid; Pseudotumor Cerebri; Sex | 1973 |